2018-2023 Global Peritoneal Cancer Market Report (Status and Outlook)

August 2018 | 135 pages | ID: 2EC7E8660EEEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Peritoneal Cancer market for 2018-2023.

Peritoneal cancer is also known as serous surface papillary carcinoma, primary peritoneal carcinoma, extra-ovarian serous carcinoma, primary serous papillary carcinoma and psammomacarcinoma.
Peritoneal cancer develops in a thin layer of tissue that lines the abdomen. It also covers the uterus, bladder and rectum.
Over the next five years, LPI(LP Information) projects that Peritoneal Cancer will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Peritoneal Cancer market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Surgery
• Chemotherapy (Anticancer Drugs)

Segmentation by application:

• Cancer Research Centers
• Cancer Hospital
• Surgical Centers
• Clinics

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• AstraZeneca
• GlaxoSmithKline
• Oxford BioMedica
• Millennium Pharmaceuticals
• Novartis
• Bayer
• Incyte
• EntreMed
• Oncolytics Biotech
• Synta Pharmaceuticals
• Oasmia Pharmaceutical

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Peritoneal Cancer market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Peritoneal Cancer market by identifying its various subsegments.
• Focuses on the key global Peritoneal Cancer players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Peritoneal Cancer with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Peritoneal Cancer submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Peritoneal Cancer Market Size 2013-2023
  2.1.2 Peritoneal Cancer Market Size CAGR by Region
2.2 Peritoneal Cancer Segment by Type
  2.2.1 Surgery
  2.2.2 Chemotherapy (Anticancer Drugs)
  2.2.3 Radiotherapy (High-Energy Rays)
2.3 Peritoneal Cancer Market Size by Type
  2.3.1 Global Peritoneal Cancer Market Size Market Share by Type (2013-2018)
  2.3.2 Global Peritoneal Cancer Market Size Growth Rate by Type (2013-2018)
2.4 Peritoneal Cancer Segment by Application
  2.4.1 Cancer Research Centers
  2.4.2 Cancer Hospital
  2.4.3 Surgical Centers
  2.4.4 Clinics
2.5 Peritoneal Cancer Market Size by Application
  2.5.1 Global Peritoneal Cancer Market Size Market Share by Application (2013-2018)
  2.5.2 Global Peritoneal Cancer Market Size Growth Rate by Application (2013-2018)

3 GLOBAL PERITONEAL CANCER BY PLAYERS

3.1 Global Peritoneal Cancer Market Size Market Share by Players
  3.1.1 Global Peritoneal Cancer Market Size by Players (2016-2018)
  3.1.2 Global Peritoneal Cancer Market Size Market Share by Players (2016-2018)
3.2 Global Peritoneal Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PERITONEAL CANCER BY REGIONS

4.1 Peritoneal Cancer Market Size by Regions
4.2 Americas Peritoneal Cancer Market Size Growth
4.3 APAC Peritoneal Cancer Market Size Growth
4.4 Europe Peritoneal Cancer Market Size Growth
4.5 Middle East & Africa Peritoneal Cancer Market Size Growth

5 AMERICAS

5.1 Americas Peritoneal Cancer Market Size by Countries
5.2 Americas Peritoneal Cancer Market Size by Type
5.3 Americas Peritoneal Cancer Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Peritoneal Cancer Market Size by Countries
6.2 APAC Peritoneal Cancer Market Size by Type
6.3 APAC Peritoneal Cancer Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Peritoneal Cancer by Countries
7.2 Europe Peritoneal Cancer Market Size by Type
7.3 Europe Peritoneal Cancer Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Peritoneal Cancer by Countries
8.2 Middle East & Africa Peritoneal Cancer Market Size by Type
8.3 Middle East & Africa Peritoneal Cancer Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL PERITONEAL CANCER MARKET FORECAST

10.1 Global Peritoneal Cancer Market Size Forecast (2018-2023)
10.2 Global Peritoneal Cancer Forecast by Regions
  10.2.1 Global Peritoneal Cancer Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Peritoneal Cancer Forecast by Type
10.8 Global Peritoneal Cancer Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 AstraZeneca
  11.1.1 Company Details
  11.1.2 Peritoneal Cancer Product Offered
  11.1.3 AstraZeneca Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 AstraZeneca News
11.2 GlaxoSmithKline
  11.2.1 Company Details
  11.2.2 Peritoneal Cancer Product Offered
  11.2.3 GlaxoSmithKline Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 GlaxoSmithKline News
11.3 Oxford BioMedica
  11.3.1 Company Details
  11.3.2 Peritoneal Cancer Product Offered
  11.3.3 Oxford BioMedica Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Oxford BioMedica News
11.4 Millennium Pharmaceuticals
  11.4.1 Company Details
  11.4.2 Peritoneal Cancer Product Offered
  11.4.3 Millennium Pharmaceuticals Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Millennium Pharmaceuticals News
11.5 Novartis
  11.5.1 Company Details
  11.5.2 Peritoneal Cancer Product Offered
  11.5.3 Novartis Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Novartis News
11.6 Bayer
  11.6.1 Company Details
  11.6.2 Peritoneal Cancer Product Offered
  11.6.3 Bayer Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Bayer News
11.7 Incyte
  11.7.1 Company Details
  11.7.2 Peritoneal Cancer Product Offered
  11.7.3 Incyte Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Incyte News
11.8 EntreMed
  11.8.1 Company Details
  11.8.2 Peritoneal Cancer Product Offered
  11.8.3 EntreMed Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 EntreMed News
11.9 Oncolytics Biotech
  11.9.1 Company Details
  11.9.2 Peritoneal Cancer Product Offered
  11.9.3 Oncolytics Biotech Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Oncolytics Biotech News
11.10 Synta Pharmaceuticals
  11.10.1 Company Details
  11.10.2 Peritoneal Cancer Product Offered
  11.10.3 Synta Pharmaceuticals Peritoneal Cancer Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 Synta Pharmaceuticals News
11.11 Oasmia Pharmaceutical

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Peritoneal Cancer
Figure Peritoneal Cancer Report Years Considered
Figure Market Research Methodology
Figure Global Peritoneal Cancer Market Size Growth Rate 2013-